Reid Gary, Devaney Madonna L, Baldwin Simon
Centre for Harm Reduction, Burnet Institute, Melbourne, Victoria, Australia.
Drug Alcohol Rev. 2006 Nov;25(6):647-50. doi: 10.1080/09595230600972850.
We report here on illicit drug production, trafficking and transit routes found in the Asia Pacific region. The report is based on the 'Situational analysis of illicit drug issues and responses in Asia and the Pacific', commissioned by the Australian National Council on Drugs Asia Pacific Drug Issues Committee. The situational analysis was a comprehensive desk based review; data sources included published and unpublished literature and key informant reports. It was found that Myanmar was the main producer of opium, heroin and amphetamine-type stimulants (ATS) in the Asia-Pacific region. China is now considered a major producer of methamphetamines, but other Asia-Pacific nations are also involved in production. Cannabis production was found throughout most of the Asia-Pacific region, in particular Cambodia and the Philippines. Drug trafficking and transit routes of Asia and the Pacific were proliferating and dynamic. The Pacific is mainly known as a trans-shipment point for drugs entering other countries in the region. Drug cultivation and production in Asia is substantial. The expansion of ATS production in the Asia Pacific region is causing much concern. Most drug traffickers change routes and tactics to exploit available vulnerable points along international borders. Responding effectively to the complexity and scale of drug production and trafficking in the Asia-Pacific region will remain a major challenge.
我们在此报告亚太地区发现的非法毒品生产、贩运及转运路线。本报告基于澳大利亚全国毒品与犯罪问题委员会亚太毒品问题委员会委托开展的“亚太地区非法毒品问题及应对措施的态势分析”。该态势分析是一项基于案头工作的全面审查;数据来源包括已发表和未发表的文献以及关键信息提供者报告。研究发现,缅甸是亚太地区鸦片、海洛因和苯丙胺类兴奋剂(ATS)的主要生产国。中国目前被视为甲基苯丙胺的主要生产国,但其他亚太国家也参与生产。在亚太地区大部分地区都发现了大麻种植,尤其是柬埔寨和菲律宾。亚太地区的毒品贩运和转运路线不断扩散且动态变化。太平洋地区主要是毒品进入该地区其他国家的转运点。亚洲的毒品种植和生产规模巨大。亚太地区苯丙胺类兴奋剂生产的扩张令人深感担忧。大多数毒贩会改变路线和策略,利用国际边境沿线现有的薄弱环节。有效应对亚太地区毒品生产和贩运的复杂性及规模仍将是一项重大挑战。